Daniel Carrasco, M.D. – FDA Inspection, Feb 28, 2024

Record Details

This FDA Inspection record concerns Daniel Carrasco, M.D., with an inspection on February 28, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Daniel Carrasco, M.D.
Inspection Date: February 28, 2024
Product Type: Drugs
Office: Center for Drug Evaluation and Research
Person: Joanne M. Schlossin (Issuing Officer)

View Company Profile

ID · c40fe8be-3227-4a7b-847f-65f080d254eb

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number: 1231441
FDA center: Human Drugs
Project area: Bioresearch Monitoring

FDA Citations

21 CFR 312.60FD-1572, protocol compliance

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Daniel Carrasco, M.D.

FDA Inspection

Daniel Carrasco, M.D.February 28, 2024